Hemolytic anemia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hemolytic anemia}} | {{Hemolytic anemia}} | ||
{{CMG}} | {{CMG}} {{shyam}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
Revision as of 02:16, 16 October 2017
|
Hemolytic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemolytic anemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hemolytic anemia epidemiology and demographics |
|
Risk calculators and risk factors for Hemolytic anemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Epidemiology and Demographics
- Worldwide, the incidence of autoimmune hemolytic anemia is 0.8 per 100,000 persons.[1]
- Worldwide, the prevalence of autoimmune hemolytic anemia is 17 per 100,000 persons.[1]
Gender
- Hemolytic anemia affects men and women equally.
Race
- Hemolytic anemia affects all races equally.
References
- ↑ 1.0 1.1 Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ; et al. (2011). "Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases". Korean J Hematol. 46 (2): 111–7. doi:10.5045/kjh.2011.46.2.111. PMC 3128891. PMID 21747883.